BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12639557)

  • 1. Exploring new non-sugar sulfated molecules as activators of antithrombin.
    Gunnarsson GT; Desai UR
    Bioorg Med Chem Lett; 2003 Feb; 13(4):679-83. PubMed ID: 12639557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of designed sulfated flavanoids with antithrombin: lessons on the design of organic activators.
    Gunnarsson GT; Desai UR
    J Med Chem; 2002 Sep; 45(20):4460-70. PubMed ID: 12238925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing small, nonsugar activators of antithrombin using hydropathic interaction analyses.
    Gunnarsson GT; Desai UR
    J Med Chem; 2002 Mar; 45(6):1233-43. PubMed ID: 11881992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.
    Al-Horani RA; Liang A; Desai UR
    J Med Chem; 2011 Sep; 54(17):6125-38. PubMed ID: 21800826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function.
    Henry BL; Connell J; Liang A; Krishnasamy C; Desai UR
    J Biol Chem; 2009 Jul; 284(31):20897-908. PubMed ID: 19497853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydropathic interaction analyses of small organic activators binding to antithrombin.
    Gunnarsson GT; Desai UR
    Bioorg Med Chem; 2004 Feb; 12(3):633-40. PubMed ID: 14738974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 2-sulfated, 3-linked alpha-L-galactan is an anticoagulant polysaccharide.
    Pereira MS; Vilela-Silva AC; Valente AP; Mourão PA
    Carbohydr Res; 2002 Nov; 337(21-23):2231-8. PubMed ID: 12433487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavonoids with an oligopolysulfated moiety: a new class of anticoagulant agents.
    Correia-da-Silva M; Sousa E; Duarte B; Marques F; Carvalho F; Cunha-Ribeiro LM; Pinto MM
    J Med Chem; 2011 Jan; 54(1):95-106. PubMed ID: 21138266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of per-sulfated flavonoids using 2,2,2-trichloro ethyl protecting group and their factor Xa inhibition potential.
    Gunnarsson GT; Riaz M; Adams J; Desai UR
    Bioorg Med Chem; 2005 Mar; 13(5):1783-9. PubMed ID: 15698795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
    Scully MF; Ellis V; Shah N; Kakkar V
    Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.
    Futamura A; Beechem JM; Gettins PG
    Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin activation by nonsulfated, non-polysaccharide organic polymer.
    Monien BH; Desai UR
    J Med Chem; 2005 Feb; 48(4):1269-73. PubMed ID: 15715496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of potentiation of antithrombin III and heparin cofactor II inhibition by sulfated xylans.
    Carson L; Doctor VM
    Thromb Res; 1990 May; 58(4):367-81. PubMed ID: 1972302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of factor Xa with heparin does not contribute to the inhibition of factor Xa by antithrombin III-heparin.
    Owen BA; Owen WG
    Biochemistry; 1990 Oct; 29(40):9412-7. PubMed ID: 2248954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On designing non-saccharide, allosteric activators of antithrombin.
    Raghuraman A; Liang A; Krishnasamy C; Lauck T; Gunnarsson GT; Desai UR
    Eur J Med Chem; 2009 Jun; 44(6):2626-31. PubMed ID: 18996625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence variation in heparin octasaccharides with high affinity for antithrombin III.
    Atha DH; Stephens AW; Rimon A; Rosenberg RD
    Biochemistry; 1984 Nov; 23(24):5801-12. PubMed ID: 6525337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfated galactan is a catalyst of antithrombin-mediated inactivation of alpha-thrombin.
    Melo FR; Pereira MS; Monteiro RQ; Foguel D; Mourão PA
    Biochim Biophys Acta; 2008 Sep; 1780(9):1047-53. PubMed ID: 18558097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides.
    Wall D; Douglas S; Ferro V; Cowden W; Parish C
    Thromb Res; 2001 Aug; 103(4):325-35. PubMed ID: 11562342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III.
    Atha DH; Lormeau JC; Petitou M; Rosenberg RD; Choay J
    Biochemistry; 1987 Oct; 26(20):6454-61. PubMed ID: 3427019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.